Overview

Reducing Total Cardiovascular Risk in an Urban Community

Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
PLEASE NOTE: THIS STUDY IS ONLY ENROLLING PATIENTS CURRENTLY BEING TREATED AT BELAIR-EDISON FAMILY HEALTH CENTER. The purpose of this study is to compare the clinical effectiveness and cost effectiveness of two cardiovascular risk reduction programs - a comprehensive intensive (Cl) intervention with a less intensive (LI) intervention - in African American, and white low-income patients with known excessive cardiovascular disease risk.
Phase:
Phase 4
Details
Lead Sponsor:
Johns Hopkins University
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Treatments:
Adrenergic beta-Antagonists
Angiotensin-Converting Enzyme Inhibitors
Atenolol
Lisinopril
Metoprolol
Platelet Aggregation Inhibitors
Propranolol